H101
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for H101, covering 2020-05-21 to 2026-04-22. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer [Phase 2]